A carregar...
Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open‐angle glaucoma and ocular hypertension
Latanoprostene bunod (LBN) ophthalmic solution 0.024% is a novel, once‐daily, nitric oxide‐donating prostaglandin analogue for the lowering of intraocular pressure (IOP) in patients with open‐angle glaucoma and ocular hypertension. The IOP‐lowering actions of LBN are mediated by dual mechanisms of t...
Na minha lista:
| Publicado no: | Clin Exp Optom |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Publishing Asia Pty Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899723/ https://ncbi.nlm.nih.gov/pubmed/30614563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cxo.12853 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|